NCT05170399 2026-02-05Vaccine Responses in Patients With B Cell MalignanciesNational Institutes of Health Clinical Center (CC)Phase 4 Recruiting500 enrolled
NCT02518555 2026-01-07Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaOhio State University Comprehensive Cancer CenterPhase 2 Active not recruiting42 enrolled